252 related articles for article (PubMed ID: 20348948)
1. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
[TBL] [Abstract][Full Text] [Related]
2. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract][Full Text] [Related]
3. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
4. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter.
Zhang P; Tchou-Wong KM; Costa M
Cancer Res; 2007 Oct; 67(19):9125-33. PubMed ID: 17909017
[TBL] [Abstract][Full Text] [Related]
5. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
[TBL] [Abstract][Full Text] [Related]
6. Tbx2 represses expression of Connexin43 in osteoblastic-like cells.
Chen JR; Chatterjee B; Meyer R; Yu JC; Borke JL; Isales CM; Kirby ML; Lo CW; Bollag RJ
Calcif Tissue Int; 2004 Jun; 74(6):561-73. PubMed ID: 15354864
[TBL] [Abstract][Full Text] [Related]
7. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
[TBL] [Abstract][Full Text] [Related]
8. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
9. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells.
Kuljaca S; Liu T; Dwarte T; Kavallaris M; Haber M; Norris MD; Martin-Caballero J; Marshall GM
Carcinogenesis; 2009 Nov; 30(11):1865-71. PubMed ID: 19773351
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle regulation of the T-box transcription factor tbx2.
Bilican B; Goding CR
Exp Cell Res; 2006 Jul; 312(12):2358-66. PubMed ID: 16730707
[TBL] [Abstract][Full Text] [Related]
15. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
16. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
18. Ectopic Tbx2 expression results in polyploidy and cisplatin resistance.
Davis E; Teng H; Bilican B; Parker MI; Liu B; Carriera S; Goding CR; Prince S
Oncogene; 2008 Feb; 27(7):976-84. PubMed ID: 17700536
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
20. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]